SRL has successfully submitted its first US Drug Master File (USDMF) for Bortezomib through ESG gateway to USFDA

SRL has been granted CEP for Busulfan and Clonidine HCl. In addition, it has successfully submitted CEP application for Temozolomide and Pirfenidone.